The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient self-reporting of tolerability using PRO-CTCAE: A randomized double-blind placebo controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in women with platinum resistant epithelial ovarian cancer.
 
Ainhoa Madariaga
Honoraria - AstraZeneca Canada
 
Sandra A. Mitchell
No Relationships to Disclose
 
Tyler Pittman
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Valerie Bowering
No Relationships to Disclose
 
Nisan Kavak
No Relationships to Disclose
 
Judy Quintos
No Relationships to Disclose
 
Karen Chang
Employment - AstraZeneca Canada
 
Janelle Ramsahai
No Relationships to Disclose
 
Katherine Karakasis
No Relationships to Disclose
 
Stephen Welch
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Pfizer; Roche Canada
Consulting or Advisory Role - Amgen; Eisai
 
Neesha C. Dhani
Honoraria - AstraZeneca
 
Stephanie Lheureux
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Amit M. Oza
(OPTIONAL) Uncompensated Relationships - Ozmosis Research